Back
Structure Therapeutics 10K Form
Buy
69
GPCR
Structure Therapeutics
Last Price:
40.49
Seasonality Move:
120.41%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GPCR News And Ratings
See the #1 stock for the next 7 days that we like better than GPCR
GPCR Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-26.82M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $16.10 |
| Price / Book: | 2.54 |
Profitability
| EPS (TTM): | -2.22000 |
|---|---|
| Net Income (TTM): | $-100.44M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Structure Therapeutics Earnings Forecast
Key Structure Therapeutics Financial Ratios
- Per Share Earnings over the last 4 years have been positive in 1 years.
Structure Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | GPCR |
| Website: | structuretx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
GPCR Technical Analysis vs Fundamental Analysis
Buy
69
Structure Therapeutics (GPCR)
is a Buy
Is Structure Therapeutics a Buy or a Sell?
-
Structure Therapeutics stock is rated a Buy
The current Structure Therapeutics [GPCR] share price is $40.84. The Score for GPCR is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.